Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Less than 4%, but of that 4 pct what percentage are earned by small bio techs that outsource to a CRO compared to large pharma. The dose justification and RO may not be newsworthy, but they are a step in the right direction Dr Rechnor is a step in the right direction.
Gardener just joined the board.
Maybe she’s been a little busy.
They were included.
That’s my recollection
I’m curious about this as well. There was a poster here at that time that continually posted that Pestell never transferred all of his patents.
It’s relevant to me - Pestell’s shares form the basis for the 13D to make their case.
He said he already had negotiations. As soon as the deal was done, Pestell bragged about his lab in Philadelphia and took the first plane to Florida and rented office space for our headquarters. The plan for these people to form a team to accomplish anything was doomed from the start. If some members of the board already had severe reservations about Nader at that time, why did they leave him in place? I’m reading 3Xs daily posts about Tony Cs concerns and wondering why did he leave him in place?
I can attest to those sentiments.
My favorite quote from my husband this morning after providing him a synopsis of this stock and the players, “that’s a lot of drama for no revenue”.
Dr Kelly did say he’s been traveling and visiting universities.
Agreed.
I think their footsteps are being heard by current management. Dr Kelly is visiting Universities to build alliances for future studies and Dr Rechnor is including bio markers in current studies. As their voices rise, others can fade.
They want to study the single person who didn’t respond in long haulers and they’re collecting bio markers on Nash trial participants to better understand the MOA in each disease they’re testing. I understand and appreciate a process driven approach. I’m not bailing now.
Good luck Humble. I’m waiting for Dr Rechnor and more info on his bio markers as well as the HIV CMC submission June 30th and will then reassess.
I’m sorry Dr Rechnor had COVID19 but thank heavens he did and was treated by Leronlimab. Great logical call describing their process.
I’ve read it. I’m not looking for a conspiracy. I want a board with MDs and MBAs, not a gymnast living in Vancouver WA who is on the comp committee.
My interpretation of Dr Jay’s interview is the FDA doesn’t understand Leronlimab’s method of action as it is being evaluated by the anti viral division - and it’s not an anti viral. He said he believed Nader to be a man of integrity. That said, someone at the company has to have a dialogue with the FDA. Did we outsource that to Amarexco? We’ve always had a revolving door at chief science officer and as long as I’ve been here I thought that was a mistake. I think Bruce did a great job of explaining the MOA at TEDX and our stock price reflected that. Grip has outlined what a M&A executive would do with CYDY to get the company back on track and it isn’t pretty. My catalyst is learning what we learned from the bio markers Dr Rechnor described on prior calls and how that information shaped the endpoints for phase 3. My faith in the company is riding on Dr R.
Misiu, thanks for all you do to share your knowledge and information here. I appreciate you!
Just curious what system you use to see the Fife trades. Seriously would like to check it out. Thank you
Probably where Ajinomoto Bio-Pharma Services executes fill and finish services.
Absolutely, but it was written in 2020
One of my favorite quotes, remdesivir, a drug in search of a disease. It had never been approved for marketing.
https://science.thewire.in/health/remdesivir-a-drug-in-search-of-a-disease/
I don’t think Misiu speaking to a subcommittee is threatening anyone. I think she provides a unique perspective on the current covid crisis. Hopefully they speak with the Doctors she recommended. Everyone has their strengths. Grip has provided some excellent analysis based on his experience in the last few days about what could happen if the international trials don’t go our way. I don’t always agree with him or enjoy his style of writing , but I appreciate what he has to offer.
Huh? I said thank you to Misiu who’s been invaluable to me by explaining the science since she bought in five years ago. I wouldn’t be qualified to speak to a subcommittee. But as an American who cares about others, is against corruption, believes in equal opportunity I wouldn’t hesitate to write to my elected officials, or the head of a government department I believe is corrupt with my constructive observations. I don’t consider that harassment, it’s my duty. It really doesn’t matter how many shares I own - and it’s more than 10k.
Thank you Misiu!!
DolphinT0m, I’m so sorry you’re not being listened to on behalf of your friend and fellow shareholder. Does his family know he’s a shareholder? Did he ever post here or on the other boards? Anything you can show them that support the belief we have in Leronlimab?
There was a pr on Aug 19 that they forwarded their top line report on CD10 to MHRA requesting a fast track path based on statically significant NEWS2 results.
Unless he was lying to them as well. I’m blown away by the News 2 not being a secondary endpoint.
What is our dosing in the HIV and cancer trials? They don’t stop at two.
Informative call. Appreciate Dr Recknor’s contributions. Just wish Nader would stop with his hissy fits when he gets a question which displeases him.
Shout it Rockleo! Great post, but so aggravating and exasperating.
Thank you for writing and sharing your touching story. Your pain and fear is evident and your love drove your determination. I hope its enough to attract the attention it deserves and results in the FDA granting EUA. Thank you for sharing
Thank you Misiu for your translation of the medical jargon and mostly for your passion expressed for treating all patients. I have a strong belief in this molecule, but I’m not in the medical field, so at times I questioned holding on. Investing in an OTC stock goes against all my experiences and education, so thank you for staying on the boards despite the frequent attacks. Today is a good day!
Dr John Bream received an email from the head of the AMA that they’ll discuss Leronlimab on their next call on therapeutics. He posted the communique to the FB group.
Or the caller could day, I’ve followed a drug in development for HIV for a number of years. It’s a large molecule CCR5 antagonist named Leronlimab. They have also begun testing with triple negative breast cancer and like the rest of the medical community have learned much about CCR5 and how it acts like a GPS for certain cells. Since the start of the pandemic they’ve applied this knowledge to covid19 and have run two trials. The virologist, Dr Bruce Patterson, spoke about the method of action in his TED-X talk in April 2020 and how several patients on ECMO recovered. Harish Seethamraju, M.D., Medical Director for the Mount Sinai Lung Transplantation Program, commented, “The CD12 trial results are very promising and leronlimab may be the only safe medication to help critically ill patients.” Cytodyn completed its trial for severe/critical and had compelling results for the critical on mechanical ventilation. They are requesting a conditional EUA and I hope you grant it and give this population a chance at life.
I signed too.
Always enjoy your insight Saltz. I’m on house money, but it still smarts, but I’m not ready to let go. My best regards to you
I agree with your statements.